Attention-deficit/Hyperactivity Disorder (ADHD), once considered solely a childhood condition, is now recognized as a persistent, lifelong neurodevelopmental disorder with significant clinical implications in adulthood. Despite its prevalence, adult ADHD remains underdiagnosed and undertreated, contributing to substantial functional impairments across occupational, social, and familial domains. High rates of psychiatric comorbidities, including substance use disorders (SUD), mood disorders, and anxiety, further compound the burden. Adults with ADHD are often missed due to cognitive biases, symptom overlap with other psychiatric conditions, masking by environmental supports, and a lack of clinician awareness and training. Importantly, ADHD in adults is treatable, with both pharmacological and non-pharmacological interventions improving outcomes when recognized early. A developmental and lifespan perspective, coupled with greater emphasis on clinician education, routine screening in general and specialty clinics, and expanded research efforts, is critical to enhancing diagnosis and care. This viewpoint underscores the need for shifting clinical practice and public health policies to better address adult ADHD, a hidden yet highly treatable condition with profound implications for individuals and society.
Shah et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: